133 related articles for article (PubMed ID: 14526460)
1. [Assessment of the studies. Important recombinant agents in treatment of rheumatoid arthritis].
Kaltwasser JP
Pharm Unserer Zeit; 2003; 32(5):396-403. PubMed ID: 14526460
[No Abstract] [Full Text] [Related]
2. [When do we use which drugs? Procedures for the treatment of rheumatoid arthritis].
Bolten WW
Pharm Unserer Zeit; 2003; 32(5):405-12. PubMed ID: 14526461
[No Abstract] [Full Text] [Related]
3. [Questions and answers. Rheumatic patients under treatment with recombinant drugs].
Karger T; Missler-Karger B
Pharm Unserer Zeit; 2003; 32(5):414-8. PubMed ID: 14526462
[No Abstract] [Full Text] [Related]
4. [Two classes of medicine: what are the consequences of treatment advances with new recombinant proteins?].
Dingermann T; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2003; 32(5):361. PubMed ID: 14526455
[No Abstract] [Full Text] [Related]
5. [Kineret, Enbrel, Remicade and company. Recombinant drugs in rheumatoid arthritis].
Zündorf I; Dingermann T
Pharm Unserer Zeit; 2003; 32(5):376-83. PubMed ID: 14526457
[No Abstract] [Full Text] [Related]
6. [Cost effectiveness of pharmaceutical innovations. Health economic aspects of rheumatoid arthritis treatment with TNF-alpha antagonists].
Kulp W; Greiner W; Graf von der Schulenburg JM
Pharm Unserer Zeit; 2003; 32(5):420-5. PubMed ID: 14526463
[No Abstract] [Full Text] [Related]
7. Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus.
Yazici Y; Erkan D
Arthritis Rheum; 2003 Dec; 48(12):3611; author reply 3613-5. PubMed ID: 14674017
[No Abstract] [Full Text] [Related]
8. [Modern therapy of rheumatoid arthritis. Joint destruction can be delayed].
Neumaier J
MMW Fortschr Med; 2008 Apr; 150(14):14. PubMed ID: 18488571
[No Abstract] [Full Text] [Related]
9. Therapeutic strategies for rheumatoid arthritis.
Smolen JS; Steiner G
Nat Rev Drug Discov; 2003 Jun; 2(6):473-88. PubMed ID: 12776222
[TBL] [Abstract][Full Text] [Related]
10. [Gold preparations in the treatment of rheumatoid arthritis].
Taukumova LA
Ter Arkh; 2002; 74(2):82-7. PubMed ID: 11899836
[No Abstract] [Full Text] [Related]
11. Do all drugs and treatments for rheumatoid arthritis have the same efficacy?
Weisman MH
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):298-9. PubMed ID: 18431369
[No Abstract] [Full Text] [Related]
12. [Levamisole used in rheumatoid arthritis].
Veys EM; Mielants H
Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
[No Abstract] [Full Text] [Related]
13. Infliximab treatment of rheumatoid arthritis.
Maini SR
Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
[TBL] [Abstract][Full Text] [Related]
14. Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers.
Pincus T
Arthritis Rheum; 2004 Apr; 50(4):1351; author reply 1351-2. PubMed ID: 15077322
[No Abstract] [Full Text] [Related]
15. Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in opposition.
Boers M
Arthritis Rheum; 2005 Jun; 52(6):1642-5. PubMed ID: 15934132
[No Abstract] [Full Text] [Related]
16. Are excellent systematic reviews of clinical trials useful for patient care?
Pincus T; Yazici Y; Sokka T
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):294-5. PubMed ID: 18461062
[No Abstract] [Full Text] [Related]
17. Are biologics more effective than classical disease-modifying antirheumatic drugs?
Nurmohamed MT; Dijkmans BA
Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
[TBL] [Abstract][Full Text] [Related]
18. It is the best of times; it is the worst of times: is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues.
O'Dell JR
Arthritis Rheum; 2007 Dec; 56(12):3884-6. PubMed ID: 18050217
[No Abstract] [Full Text] [Related]
19. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L; Schindler JD
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S79-88. PubMed ID: 18240222
[TBL] [Abstract][Full Text] [Related]
20. Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in favor.
Siegel JN; Zhen BG
Arthritis Rheum; 2005 Jun; 52(6):1637-41. PubMed ID: 15934067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
